New Vernon Investment Management LLC acquired a new stake in MetLife, Inc. (NYSE:MET - Free Report) during the fourth quarter, according to its most recent disclosure with the SEC. The institutional investor acquired 4,042 shares of the financial services provider's stock, valued at approximately $331,000.
Several other large investors have also recently added to or reduced their stakes in the company. Anchor Investment Management LLC raised its stake in MetLife by 12.5% in the 3rd quarter. Anchor Investment Management LLC now owns 6,115 shares of the financial services provider's stock worth $504,000 after purchasing an additional 681 shares in the last quarter. World Investment Advisors LLC acquired a new stake in shares of MetLife in the third quarter valued at approximately $336,000. Wilmington Savings Fund Society FSB bought a new stake in shares of MetLife in the third quarter valued at approximately $701,000. Tidal Investments LLC grew its position in MetLife by 3.9% during the third quarter. Tidal Investments LLC now owns 19,282 shares of the financial services provider's stock worth $1,590,000 after buying an additional 718 shares in the last quarter. Finally, Synovus Financial Corp increased its stake in MetLife by 5.5% during the 3rd quarter. Synovus Financial Corp now owns 22,720 shares of the financial services provider's stock worth $1,874,000 after acquiring an additional 1,183 shares during the period. Institutional investors own 94.99% of the company's stock.
Analyst Upgrades and Downgrades
MET has been the topic of several analyst reports. Piper Sandler increased their target price on MetLife from $92.00 to $94.00 and gave the stock an "overweight" rating in a report on Wednesday, April 2nd. UBS Group raised their target price on shares of MetLife from $94.00 to $98.00 and gave the company a "buy" rating in a report on Wednesday, April 2nd. JPMorgan Chase & Co. cut their price target on shares of MetLife from $88.00 to $86.00 and set an "overweight" rating for the company in a report on Wednesday, April 2nd. Morgan Stanley decreased their price objective on shares of MetLife from $109.00 to $94.00 and set an "overweight" rating on the stock in a research note on Thursday, April 10th. Finally, Cowen reissued a "buy" rating on shares of MetLife in a report on Friday, March 7th. Two research analysts have rated the stock with a hold rating and thirteen have given a buy rating to the stock. According to MarketBeat, MetLife presently has a consensus rating of "Moderate Buy" and a consensus target price of $92.46.
Read Our Latest Research Report on MET
MetLife Stock Performance
NYSE:MET opened at $75.86 on Friday. The stock's 50-day moving average is $78.49 and its 200-day moving average is $81.87. MetLife, Inc. has a 1-year low of $65.21 and a 1-year high of $89.05. The company has a current ratio of 0.16, a quick ratio of 0.16 and a debt-to-equity ratio of 0.54. The stock has a market cap of $51.68 billion, a P/E ratio of 12.71, a price-to-earnings-growth ratio of 0.65 and a beta of 0.89.
MetLife (NYSE:MET - Get Free Report) last announced its quarterly earnings results on Wednesday, February 5th. The financial services provider reported $2.08 earnings per share (EPS) for the quarter, missing the consensus estimate of $2.13 by ($0.05). MetLife had a net margin of 6.19% and a return on equity of 20.42%. Equities research analysts anticipate that MetLife, Inc. will post 9.65 earnings per share for the current year.
MetLife Increases Dividend
The business also recently announced a quarterly dividend, which will be paid on Tuesday, June 10th. Shareholders of record on Tuesday, May 6th will be issued a dividend of $0.5675 per share. The ex-dividend date of this dividend is Tuesday, May 6th. This is an increase from MetLife's previous quarterly dividend of $0.55. This represents a $2.27 annualized dividend and a yield of 2.99%. MetLife's payout ratio is presently 38.02%.
About MetLife
(
Free Report)
MetLife, Inc, a financial services company, provides insurance, annuities, employee benefits, and asset management services worldwide. It operates through six segments: Retirement and Income Solutions; Group Benefits; Asia; Latin America; Europe, the Middle East and Africa; and MetLife Holdings. The company offers life, dental, group short-and long-term disability, individual disability, pet insurance, accidental death and dismemberment, vision, and accident and health coverages, as well as prepaid legal plans; administrative services-only arrangements to employers; and general and separate account, and synthetic guaranteed interest contracts, as well as private floating rate funding agreements.
Featured Articles
Want to see what other hedge funds are holding MET? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for MetLife, Inc. (NYSE:MET - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider MetLife, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and MetLife wasn't on the list.
While MetLife currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Discover the 10 Best High-Yield Dividend Stocks for 2025 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.